Ipratropium Bromide And Albuterol Sulfate Solution
Product Images NDC 62135-831

Product Visual Gallery

This gallery contains 8 technical images submitted to the FDA as part of the official labeling for Ipratropium Bromide And Albuterol Sulfate (NDC 62135-831). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Chartwell Rx, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Image Description (Ipratropium And Albuterol Sulfate Carton Label)

Packaging label for Ipratropium Bromide and Albuterol Sulfate Inhalation Solution 0.5 mg/3 mL by Chartwell RX, LLC. The label displays dosage form as inhalation solution, strength as 0.5 mg per 3 mL, indicates Rx only status, and includes instructions to protect from light and store refrigerated. The package contains multiple sterile unit-dose vials shown in a multi-panel carton design with a barcode and storage information.*

FDA Label Image

Image Description (Ipratropium And Albuterol Sulfate Figure 1)

An instructional diagram labeled as Figure 1 showing a hand holding a vial or ampule with the product name Ipratropium Albuterol. The vial is being inverted to pour or deliver solution into a small reservoir or cup attached to an inhalation device or nebulizer mouthpiece.*

FDA Label Image

Image Description (Ipratropium And Albuterol Sulfate Figure 2)

Illustration showing a close-up of an aerosol inhalation device with a hand holding it, demonstrating connection or assembly with a mouthpiece or cap. The image focuses on the parts of the respiratory inhalation solution device related to drug delivery.*

FDA Label Image

Image Description (Ipratropium And Albuterol Sulfate Figure 3)

An instructional illustration showing a person using a respiratory inhalation device. The person holds the inhaler with one hand and places the mouthpiece in their mouth, demonstrating the proper technique for inhaling the medication.*

FDA Label Image

Image Description (Ipratropium And Albuterol Sulfate Figure 4)

An instructional illustration showing a person inhaling medication from a nebulizer mask connected to a nebulizer machine. The individual is using both hands to hold the nebulizer device while inhaling the aerosolized solution through the mask.*

FDA Label Image

Image Description (Ipratropium And Albuterol Sulfate Graph)

A line graph comparing the volume in liters over time post-dosing for Albuterol, Ipratropium, and the combination Ipratropium Bromide and Albuterol Sulfate inhalation solution. The x-axis represents hours after dosing, and the y-axis represents liters, showing changes in respiratory measurement over an 8-hour period.*

FDA Label Image

Image Description (Ipratropium And Albuterol Sulfate Structure 1)

Chemical structure diagram showing a molecular structure including a benzene ring substituted with two hydroxyl groups and an ethanolamine side chain, combined with sulfuric acid as a hydrate. This represents the chemical structure of Ipratropium Bromide and Albuterol Sulfate.*

FDA Label Image

Image Description (Ipratropium And Albuterol Sulfate Structure 2)

Chemical structure diagram of Ipratropium Bromide, showing molecular bonds and atoms including nitrogen, oxygen, and bromide hydrate (Br•H2O). No other textual details are visible.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.